A bipartisan group of Oregon lawmakers plans to introduce an omnibus bill based on drug pricing transparency recommendations compiled by a task force of industry stakeholders next session, according to a lawmaker on the task force. The recommendations go further than other states’ transparency measures by targeting steps of the prescription drug supply chain beyond pharmaceutical companies and pharmacy benefit managers. “The idea is that the whole report is included, targeting every part of the supply chain. If we put...